Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells - Wikidata - wikimedia - TriplyDB

Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells

Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells

http://www.wikidata.org/entity/Q34797370

about

Apoptotic cell clearance: basic biology and therapeutic potential.Resolution of inflammation: an integrated view Emerging roles for lysophosphatidylserine in resolution of inflammation PAMPs and DAMPs: signal 0s that spur autophagy and immunity Phosphatidylserine receptors: enhancers of enveloped virus entry and infection RAGE: a new frontier in chronic airways disease Signal Transduction in Receptor for Advanced Glycation End Products (RAGE): SOLUTION STRUCTURE OF C-TERMINAL RAGE (ctRAGE) AND ITS BINDING TO mDia1 Phagocytosis of apoptotic cells in homeostasis Contribution of Defective PS Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity The multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic disease Clearance of Dying Cells by Phagocytes: Mechanisms and Implications for Disease Pathogenesis.Apoptotic cell recognition receptors and scavenger receptors.Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion Scavenger receptor structure and function in health and disease.Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complications Engulfment signals and the phagocytic machinery for apoptotic cell clearance.Disulfide bonds within the C2 domain of RAGE play key roles in its dimerization and biogenesis.HMGB1 in health and disease.Oligomerization interface of RAGE receptor revealed by MS-monitored hydrogen deuterium exchange Regulation of RAGE for attenuating progression of diabetic vascular complications.Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts.Modulation of macrophage efferocytosis in inflammation.A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer.Poly(ADP-ribosyl)ation of high mobility group box 1 (HMGB1) protein enhances inhibition of efferocytosis Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory disease Extracellular histones inhibit efferocytosis.Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma Cross talk between engulfment receptors stabilin-2 and integrin αvβ5 orchestrates engulfment of phosphatidylserine-exposed erythrocytes.The novel RAGE interactor PRAK is associated with autophagy signaling in Alzheimer's disease pathogenesis Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry.Role of phosphatidylserine receptors in enveloped virus infection.Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure.Is RAGE still a therapeutic target for Alzheimer's disease?Eat-me: autophagy, phagocytosis, and reactive oxygen species signaling.Glycated proteome: from reaction to intervention.Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.Phagocyte dysfunction, tissue aging and degeneration.The emerging role of the receptor for advanced glycation end products on innate immunity.Current understanding of the mechanisms for clearance of apoptotic cells-a fine balance.

P2860

Q26825935-D95561E5-5243-4DB3-9D0C-9D4584581D49 Q26852569-18D88517-9483-4C71-939E-9B5EC9B9907D Q26864795-1170FFF8-7EBF-4208-9BD2-A0777A2FAB61 Q27004190-1718A6F1-C6B9-4EFA-A7E3-2EB4D066232B Q27015034-B23D8FB3-3605-4D8B-80F8-8D9B7F77A752 Q27025295-8F601F24-DA00-458D-9AFD-CD7C7EB64974 Q27676382-EB545025-0D57-41DB-94D9-FA32007D1751 Q28081044-38FE5B5A-B353-4EB8-9C9D-1FCFE03FE6D8 Q28397407-683A4E2D-BCB2-43E7-A39A-96F34E3CDAED Q28830568-10FFA48A-FAFC-4FB1-803C-6AD6548A6B65 Q30276066-C8E79B83-2D2A-4A87-910D-F854A927B5A3 Q30277892-4E46BB93-4886-4A2A-AF8F-262BBEFEFAB6 Q30408786-59809E89-B0D2-4826-A604-D943F74B7704 Q30958610-82B939B3-7725-4D87-85A0-AB6CF21EBAD2 Q33609776-470986DB-43D6-4461-850E-DA51B2294319 Q33754060-B99767D7-3889-4922-963B-86F084C3B651 Q34531584-DAE23534-6EB3-4162-A86F-A7E3982526D9 Q34622835-0A1DAF7A-DC08-41AB-8CF6-9E8AC6B99D52 Q35009387-A5F05C61-5A13-4B23-941B-C6954387E9B9 Q35494903-4B1BC82F-5AB1-4B6A-B9A9-940959425EC3 Q35579991-32F146B8-CF52-40C5-A7DF-17D6378DF997 Q35797182-F75943BF-48C9-43F8-8CF5-3CD9118D235F Q35927561-8792F97E-3993-4863-9D56-3DFA43B46019 Q35928913-74229CDD-1D0C-4738-AA77-1F069541015B Q35973298-E0E119C3-B6C6-4DBA-BBE0-18EC4720D33A Q35991574-14CD6057-A0EA-4758-B4C5-0203444DBBF9 Q36130954-D452433D-0ADF-44CF-8935-58FBB2DEA31B Q36153175-BB7995F9-B811-4194-98DB-3FD54E759084 Q36155136-7B6CA12A-3716-4741-AE7A-1426F86E9777 Q36454454-93C39BEF-2282-4EB3-9FF5-3A7754A02955 Q37036794-B76785D2-D0E8-4251-B0D3-9032511E575A Q37713918-F5A60CCF-A391-4AA4-A856-8CD978F52264 Q37997993-FC820E61-0764-4489-ABA6-EE5372F09016 Q38008724-06FF2EEE-CE81-4B0D-AEE8-A87C1C324E92 Q38032609-A4EF0BFF-6316-4FAC-B35C-DF8E6FB6CEEB Q38062900-52C7BF9C-98C5-49AA-8124-D48CC3BB643B Q38079579-8BADEEE8-1B50-4681-AF04-BBD448FD8011 Q38113059-F9C74C77-8852-4449-BFAA-70CEA6050A9B Q38165257-FCFC676B-9BF8-4807-93A6-D88605D13344 Q38256349-56A75DB2-F0B3-4D07-A258-E0CEA6F97F5B

P2860

Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells

http://www.wikidata.org/entity/Q34797370

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Receptor for advanced glycatio ...... e clearance of apoptotic cells

@ast

Receptor for advanced glycatio ...... e clearance of apoptotic cells

@en

Receptor for advanced glycatio ...... e clearance of apoptotic cells

@nl

type

label

Receptor for advanced glycatio ...... e clearance of apoptotic cells

@ast

Receptor for advanced glycatio ...... e clearance of apoptotic cells

@en

Receptor for advanced glycatio ...... e clearance of apoptotic cells

@nl

prefLabel

Receptor for advanced glycatio ...... e clearance of apoptotic cells

@ast

Receptor for advanced glycatio ...... e clearance of apoptotic cells

@en

Receptor for advanced glycatio ...... e clearance of apoptotic cells

@nl

P1433

Q34797370-5FFBFDC1-A2BF-4313-9070-102A17F81CB1

P1476

Q34797370-D2F224DD-B11B-4B85-91E5-307C462E6302

P2093

Q34797370-065EAD37-E73B-4DC2-BF40-1A751188C62D

Q34797370-22963EBA-5C68-4156-9296-6F610AB4AE5C

Q34797370-5B5D26EB-0BC5-47F0-B6AA-613327793D0A

Q34797370-72D88448-6350-4D17-9FAA-30FF12778248

Q34797370-7F6902EB-F922-40BA-8A3E-C99C499FDB66

Q34797370-A199A171-CFF9-489B-8A86-F0CDA76F7E8E

Q34797370-A7D7F56D-D61F-4B0E-90E5-ED49CCDE79E7

Q34797370-D27F00CD-31A7-4683-A580-DD796E75F4DA

P2860

Q34797370-025F5F7A-5C22-4D35-9105-2C7BB20D5643

Q34797370-0ECDA846-5BDE-4735-BDE1-DC0C0E1C92D9

Q34797370-16AFD86C-BF4A-4470-9798-E26C29534A1B

Q34797370-26764959-C3B2-44BB-9C1F-F5CD63119827

Q34797370-2CB0F6AA-3C13-43E5-84B4-9F0314CDFA54

Q34797370-3161DAA6-5727-4277-9940-2A8CAFBDAB9B

Q34797370-4DB4A23A-01BB-4158-913E-40D91F05ABA3

Q34797370-52CC0B71-7AA1-4E22-992E-DB4DAA65B3EE

Q34797370-59FF61FC-D531-465F-8C8D-573717270A41

Q34797370-5BB71D17-8418-40D3-B110-94E0A5D63216

P304

Q34797370-ECF060C4-DD63-48E7-AAAC-1D2B794C867C

P31

Q34797370-1E75CF89-7993-44F9-9566-D160C9E12E7A

P356

Q34797370-D41C2EBA-5BDF-4559-9B1C-DA4EAF3E679D

P433

Q34797370-BD354E65-95CC-46F9-BA33-F43F6C6CBE60

P478

Q34797370-2A7D53AB-D503-48D7-8A01-16AAB8BE2C81

P50

Q34797370-44690BFC-F654-4449-8B62-2FAAA72FF5FF

Q34797370-62BBBC8E-A373-4B38-A975-82721FD2CBF5

Q34797370-A00EAFE3-4A16-492F-9C95-6080B9D79730

P577

Q34797370-FE14E04B-296E-45A9-A521-FFEAC38DF91E

P5875

Q34797370-347F8B04-3861-4682-9316-C3FC4F705D0A

P698

Q34797370-D60A0983-289A-4ACB-BF11-346DB0437BDB

P921

Q34797370-DBF2BE6E-D276-498C-929D-EB697AFC4FA3

P932

Q34797370-53992571-A8E3-4B73-889C-D08D6D55417E

P356

P1433

P1476

Receptor for advanced glycatio ...... e clearance of apoptotic cells

@en

P2093

Hiroshi Yamamoto

http://www.w3.org/2001/XMLSchema#string

Konosuke Morimoto

http://www.w3.org/2001/XMLSchema#string

Mei He

http://www.w3.org/2001/XMLSchema#string

Mutsuo Yamaya

http://www.w3.org/2001/XMLSchema#string

Takaya Suzuki

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Maekawa

http://www.w3.org/2001/XMLSchema#string

Toru Takahasi

http://www.w3.org/2001/XMLSchema#string

Yasuhiko Yamamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins

Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42

TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.

Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes

High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine

HMG-1 as a late mediator of endotoxin lethality in mice

alphavbeta5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells

Resolution of inflammation: the beginning programs the end

Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages

BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module.

P304

358-364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EMBOR.2011.28

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Mitsuhiro Yamada

P577

2011-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232797430

http://www.w3.org/2001/XMLSchema#string

P698

21399623

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

3077249

http://www.w3.org/2001/XMLSchema#string